- Home
- JQC vs VALN Comparison
JQC vs VALN Comparison
Compare JQC & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JQC
- VALN
- Stock Information
- Founded
- JQC 2003
- VALN 2012
- Country
- JQC United States
- VALN France
- Employees
- JQC N/A
- VALN N/A
- Industry
- JQC Finance Companies
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JQC Finance
- VALN Health Care
- Exchange
- JQC Nasdaq
- VALN Nasdaq
- Market Cap
- JQC 752.6M
- VALN 777.9M
- IPO Year
- JQC N/A
- VALN 2021
- Fundamental
- Price
- JQC $5.36
- VALN $9.95
- Analyst Decision
- JQC
- VALN Strong Buy
- Analyst Count
- JQC 0
- VALN 4
- Target Price
- JQC N/A
- VALN $15.75
- AVG Volume (30 Days)
- JQC 714.6K
- VALN 122.0K
- Earning Date
- JQC 01-01-0001
- VALN 11-06-2025
- Dividend Yield
- JQC 11.13%
- VALN N/A
- EPS Growth
- JQC N/A
- VALN N/A
- EPS
- JQC N/A
- VALN N/A
- Revenue
- JQC N/A
- VALN $230,566,060.00
- Revenue This Year
- JQC N/A
- VALN $14.76
- Revenue Next Year
- JQC N/A
- VALN $24.11
- P/E Ratio
- JQC N/A
- VALN N/A
- Revenue Growth
- JQC N/A
- VALN 25.47
- 52 Week Low
- JQC $4.82
- VALN $3.62
- 52 Week High
- JQC $5.65
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- JQC 33.72
- VALN 59.71
- Support Level
- JQC $5.48
- VALN $8.72
- Resistance Level
- JQC $5.58
- VALN $9.19
- Average True Range (ATR)
- JQC 0.04
- VALN 0.35
- MACD
- JQC -0.02
- VALN 0.02
- Stochastic Oscillator
- JQC 11.36
- VALN 93.82
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.